# The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients

> **NCT05232370** · PHASE2 · COMPLETED · sponsor: **Unidad de Investigacion Medica en Enfermedades Renales** · enrollment: 39 (actual)

## Conditions studied

- Oxidative Stress

## Interventions

- **DRUG:** Angiotensin converting enzyme inhibitor
- **DRUG:** Angiotensin Receptor Blockers

## Key facts

- **NCT ID:** NCT05232370
- **Lead sponsor:** Unidad de Investigacion Medica en Enfermedades Renales
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2022-01-06
- **Final completion:** 2022-01-06
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05232370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05232370, "The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05232370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*